Zecotek Announces Appointments to Scientific Advisory Board
Vancouver, November 26, 2007 – Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt:W1I), formerly Zecotek Medical Systems Inc., today announced it has appointed Dr. K.A. Abraham and Dr. Teoh Tiong Ann to its Advisory Board.
“We are very fortunate to welcome both Dr. Abraham and Dr. Teoh to our Advisory Board,” said Dr. A. F. Zerrouk, Chairman, President, and CEO of Zecotek. “Both Dr. Abraham and Dr. Teoh are recognized experts in their respective fields and we expect them to make significant contributions to the design and development of our medical imaging products, including our PET/MRI , our Optical Coherent Tomography device as well as a range of medical lasers used both in treatment and diagnostics.”
Dr. K.A. Abraham is a Consultant E.N.T. Surgeon who has been in private practice since 1984. He has held the position of Deputy Head at the E.N.T. Department of the SingaporeGeneralHospital, and later was the first Head of the E.N.T. Department at Tan Tock SengHospital. He helped establish the E.N.T. Department at the NationalUniversityHospital and was a visiting Consultant at the University until 2002. Dr. K.A. Abraham received his MBBS from the University of Singapore (1969). He is a Fellow of The Royal College of Surgeons, Edinburgh (1973), a member of the Academy of Medicine, Singapore and is a past President of the Society of Otolaryngology in Singapore.
Dr. Teoh Tiong Ann is a recognized expert in Laparoscopic (keyhole) surgery and is currently the Consultant Colorectal Surgeon and General Surgeon at the Mount Elizabeth Medical Centre in Singapore. He received his MBBS (1985) and Master of Medicine (Surgery)(1990) from the National University of Singapore under the auspices of a Singapore Government Public Services Commission Merit Scholarship. He is a Fellow of the Royal College of Surgeons (Edinburgh)(1990) and the Academy of Medicine, Singapore (1994). Dr. Teoh is a Founding Member of Endoscopic & Laparoscopic Surgeons of Asia and also a Founding member of the Society of Colorectal Surgeons of Singapore. He is also a Member of the American Society of Colon & Rectal Surgeons and was previously a member of the Technologies Committee of this American Society.
Zecotek has granted 160,000 stock options, to the new members of the Advisory Board, with an exercise price of $1.79 and expiration date of November 26, 2012. The stock options are subject to regulatory approval.
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I) is a photonics technology company developing high-performance crystals, photo detectors, lasers, optical imaging and 3D display technologies for commercial applications in the medical diagnostics and high-tech industry. Founded in 2003, the company has three distinct operating divisions: imaging, lasers and 3D display and labs located in Canada, USA, Singapore and Russia. Zecotek commercializes its novel, patented and patent-pending photonic technologies directly and through strategic alliances and joint ventures with multinational OEMs, distributors and other industry leaders. For more information, please visit Zecotek Photoics.
This press release may contain forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
For additional information please contact:
Zecotek Photonics Inc.
MICHAEL MINDER, CFO; VP Corporate Development, T: (604) 827-5203
Caliber Capital Partners
TIM MCNULTY, T: (778) 327-6678, E: firstname.lastname@example.org
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at Zecotek Photonics.